The Exchange had sought clarification from Akzo Nobel India Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is enclosed.
JSWDULUX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The NSE had asked Akzo Nobel India to explain discrepancies between the XBRL and PDF versions of its financial results for the quarter ended 31 March 2025, filed on 14 May 2025. The company responded on 24 June 2025, stating that the differences in figures were due to rounding off and decimal representation, not actual data mismatches. The original financial results (submitted on 14 May 2025) remain valid and unchanged. This is a routine format-related clarification under SEBI Listing Regulations, not a financial restatement.
No material impact on shareholders or the stock — the discrepancy is purely cosmetic (rounding off) and does not affect reported earnings or financials. Minor administrative compliance matter.